{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:48:59Z","timestamp":1789516139257,"version":"build-2803163510"},"reference-count":71,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Cosmetic Dermatology"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Eyelash serums, both prescription and over\u2010the\u2010counter, are gaining popularity for enhancing the appearance of eyelashes through various biologically active molecules. Categorized into prostaglandin analogs and non\u2010prostaglandin analogs, these serums claim increased strength, length, luster, and thickness. Current United States law also requires no efficacy or safety assessments by the Food and Drug Administration before approving products for consumer use, potentially posing health risks for patients seeking over\u2010the\u2010counter eyelash enhancements.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Our aims include exploring proposed benefits and adverse effects associated with eyelash serums, while providing evidence\u2010based clinical recommendations on their use. We aim to contribute valuable insights to the understanding of eyelash serums and their respective safety considerations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The authors conducted a comprehensive electronic search across databases including PubMed, Embase, Cochrane Central, and Google Scholar to evaluate eyelash serum ingredients. Articles were evaluated by two independent researchers for relevance, and the ingredients discussed were analyzed and given clinical recommendations for eyelash serums based off the Oxford Centre for Evidence\u2010Based Medicine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Results highlight bimatoprost's efficacy, supported by numerous studies evaluating safety and adverse effects. Other prostaglandin ingredients show potential benefits, but further studies are encouraged to enhance the understanding of respective safety profiles. While non\u2010prostaglandins ingredients show promising data, more studies are needed due to a lack of formal evidence in eyelash serum use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>As the cosmeceutical market for eyelash serums is growing, dermatologists need to be knowledgeable about evidence\u2010based information regarding prescription and over\u2010the\u2010counter eyelash serum products before making recommendations to patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jocd.16278","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T01:39:24Z","timestamp":1710293964000},"page":"2328-2344","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Eyelash serums: A comprehensive review"],"prefix":"10.1111","volume":"23","author":[{"given":"Maya","family":"Baiyasi","sequence":"first","affiliation":[{"name":"Wayne State University School of Medicine  Detroit Michigan USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"St.\u00a0Claire","sequence":"additional","affiliation":[{"name":"Department of Dermatology Wayne State University  Detroit Michigan USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Hengy","sequence":"additional","affiliation":[{"name":"Wayne State University School of Medicine  Detroit Michigan USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komal","family":"Tur","sequence":"additional","affiliation":[{"name":"Wayne State University School of Medicine  Detroit Michigan USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Fahs","sequence":"additional","affiliation":[{"name":"Department of Dermatology Wayne State University  Detroit Michigan USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Potts","sequence":"additional","affiliation":[{"name":"Department of Dermatology Wayne State University  Detroit Michigan USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,3,12]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S6480"},{"key":"e_1_2_10_3_1","doi-asserted-by":"crossref","unstructured":"CoreaD.Eyelash serum market to reach $1.3 BN globally by 2031 at 5.7% CAGR: allied market research.PR Newswire.2022.","DOI":"10.1016\/j.focat.2022.02.006"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.optom.2018.05.003"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09487.x"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07495.x"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000000170"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13897"},{"key":"e_1_2_10_9_1","unstructured":"Evidence OCfE\u2010bmLo.Oxford Centre for Evidence\u2010based medicine: Levels of evidence 2009.2023."},{"issue":"4","key":"e_1_2_10_10_1","first-page":"291","article-title":"Prostaglandins in dermatology","volume":"9","author":"Pustisek N","year":"2001","journal-title":"Acta Dermatovenerol Croat"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.17116\/oftalma2022138011107"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(02)00307-7"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)70870-0"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14669"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/PSN.0000000000000097"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.06.005"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2010.01522.x"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S229335"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/jidsymp.2013.30"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13443"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2009.03755.x"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1473-2165.2010.00487.x"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.4103\/0974-7753.77511"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.01.027"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00266-014-0293-7"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/cxo.12507"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.116.8.1065"},{"issue":"2","key":"e_1_2_10_28_1","first-page":"E7","article-title":"Bimatoprost\u2010induced iris hyperpigmentation: beauty in the darkened eye of the beholder","volume":"104","author":"Lipp MB","year":"2019","journal-title":"Cutis"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2012.195"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.12163"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.4103\/0974-7753.90809"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.10.017"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03543.x"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1177\/112067210601600209"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-4182(02)80004-7"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00347-002-0613-1"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-003-0039-6"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(97)80016-1"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/OPX.0b013e3182231202"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12844"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01911.x"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2008.01380.x"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2013.0075"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2006.0061"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1080\/14764170802054138"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12281"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/asj\/sjac156"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2022.114940"},{"key":"e_1_2_10_49_1","volume-title":"Blue List: Cosmetic Ingredients","author":"Kemper FH","year":"2000"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-202X(93)90516-K"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1089\/jmf.2017.4101"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2016.28.4.438"},{"issue":"10","key":"e_1_2_10_53_1","first-page":"32","article-title":"An herbal extract combination (biochanin a, acetyl tetrapeptide\u20103, and ginseng extracts) versus 3% minoxidil solution for the treatment of androgenetic alopecia: a 24\u2010week, prospective, randomized, triple\u2010blind, controlled trial","volume":"13","author":"Lueangarun S","year":"2020","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1372423"},{"issue":"2","key":"e_1_2_10_55_1","first-page":"61","article-title":"An open\u2010label, single\u2010center, safety and efficacy study of eyelash Polygrowth factor serum","volume":"13","author":"Sachdev M","year":"2020","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19092703"},{"key":"e_1_2_10_57_1","doi-asserted-by":"publisher","DOI":"10.1177\/0194599817698441"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.3511"},{"key":"e_1_2_10_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgr.2016.12.007"},{"key":"e_1_2_10_60_1","doi-asserted-by":"publisher","DOI":"10.3390\/cimb43030097"},{"key":"e_1_2_10_61_1","doi-asserted-by":"publisher","DOI":"10.1272\/jnms.JNMS.2019_86-209"},{"key":"e_1_2_10_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/ics.12559"},{"key":"e_1_2_10_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-019-03363-3"},{"key":"e_1_2_10_64_1","doi-asserted-by":"publisher","DOI":"10.3945\/jn.117.256404"},{"key":"e_1_2_10_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.13976"},{"key":"e_1_2_10_66_1","doi-asserted-by":"publisher","DOI":"10.1080\/01480545.2020.1776723"},{"key":"e_1_2_10_67_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/549721"},{"key":"e_1_2_10_68_1","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S182497"},{"key":"e_1_2_10_69_1","doi-asserted-by":"publisher","DOI":"10.5650\/jos.ess21226"},{"key":"e_1_2_10_70_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1201627109"},{"key":"e_1_2_10_71_1","volume-title":"Rodan + fields lash boost litigation: Keller Rohrback Complex Litigation","year":"2022"},{"key":"e_1_2_10_72_1","unstructured":"Grande cosmetics enhancement serums are drugs says California class action. Accessed 09\/12\/2023.https:\/\/classactionsreporter.com\/grande\u2010cosmetics\u2010enhancement\u2010serums\u2010are\u2010drugs\u2010says\u2010california\u2010class\u2010action\/"}],"container-title":["Journal of Cosmetic Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jocd.16278","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T22:22:46Z","timestamp":1718835766000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jocd.16278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,12]]},"references-count":71,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1111\/jocd.16278"],"URL":"https:\/\/doi.org\/10.1111\/jocd.16278","archive":["Portico"],"relation":{},"ISSN":["1473-2130","1473-2165"],"issn-type":[{"value":"1473-2130","type":"print"},{"value":"1473-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,12]]},"assertion":[{"value":"2023-05-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}